SUSQUEHANNA INTERNATIONAL GROUP, LLP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 73 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$331,559
+50.6%
142,300
+53.8%
0.00%
Q2 2023$220,150
+207.2%
92,500
+137.5%
0.00%
Q1 2023$71,662
+4.8%
38,947
+8.2%
0.00%
Q4 2022$68,406
+163.1%
36,003
+196.6%
0.00%
Q3 2022$26,000
-66.2%
12,140
-55.2%
0.00%
Q2 2022$77,000
-58.2%
27,117
-38.6%
0.00%
Q1 2022$184,000
-79.6%
44,200
-74.6%
0.00%
Q4 2021$900,000
+26.9%
173,740
+60.4%
0.00%
Q3 2021$709,000108,3000.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders